Recently, it has been reported that hepatic COX-2 transgenic mice are protected from streptozotocin (STZ) or high fat-induced hyperglycemia, insulin resistance, and liver damage (Carboneau, Breyer, & Gannon, 2017; Motiño et al., 2019). Here, PTGS2 is linked to Insulin resistance.